<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although carcinoembryonic antigen (CEA) is a valuable indicator for estimating the progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), some patients with advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> show no elevation of the CEA level </plain></SENT>
<SENT sid="1" pm="."><plain>On the other hand, <z:mp ids='MP_0001845'>inflammation</z:mp>-based prognosis, assessed by the Glasgow Prognostic Score (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GPS</z:e>), has been established as one of the important prognostic factors of survival after surgery for several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We estimated the postoperative survival of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> preoperative serum level of CEA on the basis of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GPS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Among 491 patients who had undergone elective <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> surgery, 271 with a <z:mpath ids='MPATH_458'>normal</z:mpath> preoperative serum CEA level (â‰¤5.0 ng/ml) were enrolled </plain></SENT>
<SENT sid="4" pm="."><plain>Uni- and multivariate analyses were performed to evaluate the relationship to overall survival </plain></SENT>
<SENT sid="5" pm="."><plain>Kaplan-Meier analysis and log rank test were used to compare the survival curves between patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GPS</z:e> 0 (group A), and 1 or 2 (group B) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Univariate analyses using clinical characteristics revealed that lymphatic invasion, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, platelet count, the serum levels of CEA and C-reactive protein, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, node, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> staging system (stage 0, I, II/III, IV), and the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GPS</z:e> (0/1, 2) were associated with overall survival </plain></SENT>
<SENT sid="7" pm="."><plain>Among these characteristics, multivariate analysis demonstrated that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GPS</z:e> and platelet count were associated with overall survival </plain></SENT>
<SENT sid="8" pm="."><plain>Kaplan-Meier analysis and log rank test demonstrated a significant difference in overall survival between groups A and B (P &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Even if <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients have a <z:mpath ids='MPATH_458'>normal</z:mpath> preoperative serum level of CEA before surgery, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GPS</z:e> is able to predict their postoperative survival </plain></SENT>
</text></document>